Summary
This phenome-wide Mendelian randomization study leveraged genetic variation in the plasma proteome to investigate causal relationships with complex diseases. By using protein quantitative trait loci as instrumental variables, the authors aimed to distinguish causal protein effects from confounded associations, thereby identifying therapeutic targets and mechanistic pathways linking circulating proteins to disease risk across multiple health conditions.
UK applicability
As a genetics-based mechanistic study of protein–disease associations, findings are broadly applicable to UK populations and could inform prioritisation of protein biomarkers for clinical investigation and drug development. However, the transferability depends on whether genetic variation in plasma protein levels is comparable across ancestral groups represented in the study cohorts.
Key measures
Genetic instruments for plasma proteins; disease risk associations; causal effect estimates derived from instrumental variable analysis
Outcomes reported
The study applied phenome-wide Mendelian randomization to identify causal relationships between circulating protein levels and risk of complex diseases across multiple health outcomes. This large-scale analysis assessed which plasma proteins have causal influences on disease susceptibility.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.